Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute plans to release a funding opportunity titled the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional programs that train clinical scientists in cancer research. This initiative seeks to increase the number of clinician-scientists skilled in clinical and translational cancer research, fostering their career growth and preparing them to collaborate effectively with basic research scientists. Each program must include at least two oncology specialties among both faculty and appointed scholars, utilize the institution's strengths and recent research advancements, and provide personalized career development plans. Mentorship is a core component, requiring two mentors per scholar—one clinician involved in patient-oriented research and one basic science cancer researcher. Funding may cover salaries for program directors, principal investigators, and scholars, along with research and administrative expenses. Programs must specify the number of scholar appointments annually, and scholars must hold full-time positions at the applicant or partner institutions. Scholars receive support for two to three years, contingent on satisfactory progress toward independent academic careers. The program accommodates scholars leading independent clinical trials, conducting ancillary studies, or gaining clinical trial research experience under another investigator. The funding opportunity is managed by the National Cancer Institute under the Department of Health and Human Services, with inquiries directed to Mark Damico, Ph.D.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), the Paul Calabresi Career Development Award for Clinical Oncology (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in cancer research. The purpose of the Paul Calabresi Career Development Award for Clinical Oncology, is to increase the number of clinician-scientists trained in clinical and translational cancer research, promote their career development, and prepare them to be effective scientific partners with basic research scientists.
NCI Calabresi K12 programs are required to have at least two oncology specialties represented among the included faculty and the pool of K12 appointees (Scholars). The programs are expected to leverage the institution’s unique strengths in these oncology specialties and to incorporate the latest research and technology advancements in designing cutting-edge career development curricula. And the programs must establish individualized career development plans to accommodate Scholars with different levels of prior research training/experience and assign two mentors, a clinician conducting patient-oriented research and a basic science cancer researcher, to each Scholar.
The award budgets may include salary support for the PD(s)/PI(s) and Scholars, research and development support, and administrative support costs. The application must clearly indicate the number of Scholar appointments proposed for each year. Candidates must have a full-time appointment at the applicant institution or a partnering institution. Scholar support is provided for a minimum of two years and a maximum of three years of consecutive funding for each scholar, consisting of 12-month appointments, provided their progress towards an independent academic career is on track and satisfactory. The program will allow the appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator as part of their research and career development.
